Circulating microRNAs as potential biomarkers in tr breast cancer translational research study of the NACATRINE trial - supplementary material

Table S1. ct-miRNA differentially expressed between pCR and RD in the carboplatin arm.<br><br>Table S2. ct-miRNA differentially expressed between pCR and RD in the non-carboplatin arm.<br><br>Table S3. Enrichment analysis of pathways with their respective genes involved - carboplatin arm.<br><br>Table S4. Enrichment analysis of pathways with their respective genes involved – non-carboplatin arm.Figure S1: Heatmap of ct-miRNA expression data using hierarchical clustering to show the difference in expression between pCR and RD.<br><br>Figure S2. Overall survival analysis by miRNA expression using Kaplan-Meier Plotter.<br><br>Figure S3. Identification of differentially expressed ct-miRNAs at baseline associated with relapse: volcano plot and boxplot analysis.<br><br>Figure S4. Top 10 categories of enriched genetic ontology (GO) revealed by target genes.